The U.S. peripheral vascular devices and accessories market size was valued at USD 3.3 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 2020 to 2027. Growing prevalence of venous diseases or Chronic Venous Insufficiency (CVI) is one of the key factors driving the growth of this market for peripheral vascular devices and accessories. In addition, growing geriatric population and increasing demand for minimally invasive endovascular procedures is further increasing its adoption.
Furthermore, increasing prevalence of atherosclerosis and Peripheral Arterial Disease (PAD) or Peripheral Vascular Disease (PVD) is one of the factors driving the market. In addition, rising geriatric population is contributing to the high incidence of PVD in the country as well as across the globe. For instance, according to CDC, in the U.S., nearly 8.5 million people have PAD, of which 12%-20% of people are above the age of 60. Thus, rising geriatric population, coupled with increasing prevalence of PAD is anticipated to boost the market for peripheral vascular devices and accessories in the coming years.
In addition, changing lifestyle and eating habits are some of the significant factors leading to an increase in the incidence of PVD, thereby boosting the demand for these devices. Various factors such as high consumption of alcohol, cigarettes, and tobacco products, and less physical activity, which is expected to propel the demand for peripheral vascular devices. For instance, according to the CDC, smoking and aging are among the risk factors for PAD.
Increasing demand for minimally invasive surgeries for treating vascular disease is an important factor driving the demand for peripheral vascular devices in the market. Minimally invasive procedures facilitate or accelerate the recovery process and cause fewer traumas to patients, thereby increasing its preference among patients. Moreover, these procedures require shorter hospital stays, which makes them more cost-effective for patients. Hence, these benefits are expected to increase the demand for peripheral vascular devices in the market.
Furthermore, minimally invasive procedures minimize post-surgery complications and reduce mortality rates. For instance, open bypass surgery was the standard for lower extremity vascular disease. However, it is associated with significant morbidity and mortality, and post-surgery complications, hence negatively impact the quality of life. Minimally invasive procedures, including balloon angioplasty, drug-eluting technologies, excisional atherectomy, or laser ablation that are significantly in improving quality of life. According to a research study published by the University of Wisconsin School of Medicine and Public Health, minor and major complications were less in patients undergoing balloon angioplasty in comparison with open surgical bypass. Hence, the increasing preference towards minimally invasive surgeries such as balloon angioplasty is likely to fuel the growth of the market for peripheral vascular devices and accessories in near future.
Moreover, an increasing number of products being recalled may negatively impact the brand image of the company, which eventually affects the demand for its existing product in the market. For instance, in 2017, Bard Peripheral Vascular, Inc. recalled Halo One Thin-Walled Guiding Sheath, which is used to guide or introduce interventional and diagnostic devices into arteries and veins. The product is recalled as the company reported that the sheath body may get detached from the sheath hub, and the sheath or its tip may become damaged during the procedure. The FDA has designated the product with Class I status, which is the most critical type of recall. Thus, product recalls of peripheral vascular devices are among the significant factors restraining market growth. However, with the changing scenario of regulations in the country and across the globe, the process of approval may become stringent in the coming years, which may reduce product recalls and promote market growth.
Based on product, peripheral vascular stents dominated the market for peripheral vascular devices and accessories and accounted for the largest revenue share of 33.7% in 2019. This high share is attributable to technological advancements in stent technology and the increasing demand for minimally invasive procedures. Furthermore, the peripheral stent market is majorly driven by a growing patient pool requiring immediate stent placement, technological innovations in peripheral vascular interventions, and a growing number of government initiatives.
In addition, peripheral accessories are expected to be the fastest-growing segment, growing at a significant growth rate over the forecast period. Growing demand for peripheral accessories in peripheral vascular interventions is one of the major factors expected to propel the growth of the market for peripheral vascular devices and accessories in the coming years. Moreover, the development of better accessories, beneficial during the peripheral vascular interventions, and enhancing the ease of accessibility is likely to boost the adoption of peripheral accessories in the coming years.
The extra support tip segment dominated the U.S. peripheral vascular devices and accessories market with a revenue share of 41.1% in 2019. Torque movement, fine control, and support provided for the treatment of complex and diffuse lesions are some of the key factors fueling market growth. In addition, these types of guidewires are also beneficial in providing support to the delivery of bulky devices. Some of the examples of extra support tip guidewires provided by Boston Scientific are PT family: PT Choice, PT Graphix, and PT 2.
Furthermore, this segment is also expected to exhibit lucrative growth over the forecast period due to its use for treatment and diagnosis of chronic occlusions, distal lesions, and tortuous anatomies. In addition, enhancement in steerability and flexibility of the guidewire due to higher tip load, availability of hydrophilic and hydrophobic variants, and power of tackling complex lesions are some of the advantages boosting the adoption of extra support guidewires, thereby propelling the growth of the market during the forecast period.
In 2019, based on guidewire coating, hydrophilic guidewire coating accounted for the highest revenue share of 80.7% in the market for peripheral vascular devices and accessories. This is owing to easy accessibility and a more slippery nature when combined with water. Furthermore, factors such as a reduction in friction and increase in trackability are expected to propel the growth of the market for peripheral vascular devices and accessories during the forecast period.
In addition, this segment is expected to witness the highest CAGR owing to benefits such as tackling tortuous lesions and help in finding microchannels in occlusions. Furthermore, increasing innovations and advancements by various players is expected to increase the adoption of guidewires with a hydrophilic coating. For instance, NaviPro guidewire, provided by Boston Scientific, is 100 percent hydrophilic guidewire useful for smooth passage through tortuous lesions or anatomy. Therefore, due to the advantages provided by hydrophilic guidewires and the increasing number of innovative guidewires with a hydrophilic coating, the market is expected to witness lucrative growth over the forecast period.
Competition is strong among existing players owing to the rise in demand for minimally invasive procedures and increasing adoption of peripheral vascular devices coupled with technological advancements. The rising demand in the market for peripheral vascular devices and accessories is likely to promote the entry of new companies in the future.
Furthermore, increase in mergers and acquisitions and partnership activities to acquire new technologies are expected to boost the competition and propel the growth of the market for peripheral vascular devices and accessories. For instance, in September 2020, Medtronic announced the acquisition of Avenu Medical. This would help in strengthening the product portfolio of the company in the peripheral vascular access business. Therefore, increasing strategic initiatives by major players in the market for peripheral vascular devices and accessories is expected to propel the growth during the forecast period. Some of the prominent players in the U.S. peripheral vascular devices and accessories market include:
Abbott Laboratories
Terumo Medical Corporation
Medtronic, Inc.
Boston Scientific Corporation
Cordis
Philips
AngioDynamics, Inc.
Asahi Intecc Co. Ltd.
Becton Dickinson and Co
BIOTRONIK
Biosensors International Group
B. Braun
iVascular
Merit Medical
Cook Group Inc.
Report Attribute |
Details |
Market size value in 2020 |
USD 3.4 billion |
Revenue forecast in 2027 |
USD 4.6 billion |
Growth Rate |
CAGR of 4.5% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Volume in units, revenue in USD million, and CAGR from 2020 to 2027 |
Report coverage |
Volume forecast, revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, guidewire coating, guidewire tip weight wire |
Country scope |
U.S. |
Key companies profiled |
Abbott Laboratories; Terumo Medical Corporation; Medtronic Inc.; Boston Scientific Corporation; Cordis; Philips; AngioDynamics, Inc.; Asahi Intecc Co. Ltd.; Becton Dickinson and Co; BIOTRONIK; Biosensors International Group; B. Braun; iVascular; Merit Medical; Cook Group Inc. |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research, Inc. has segmented the U.S. peripheral vascular devices and accessories market report on the basis of product, guidewire coating, and guidewire tip weight wire.
Product Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)
Peripheral Stents
Carotid Artery Stents
Renal Artery Stents
Femoral Artery Stents
Iliac Artery Stents
Other Peripheral Stents
PTA Balloons
Catheters
Angiography Catheters
Guiding Catheters
IVUS/OCT Catheters
Peripheral Accessories
Guidewires
Workhorse Guidewires
Frontline Finesse Guidewires
Extra Support Guidewires
Specialty Guidewires
Peripheral Vascular Closure Devices
Introducer Sheaths
Balloon Inflation Devices
Guidewire Coating Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)
Hydrophilic Coating
Hydrophobic Coating
Guidewire Tip Weight Wire Outlook (Volume, Units; Revenue, USD Million, 2016 - 2027)
Floppy Tip
Balanced Tip
Extra Support Tip
b. The U.S. peripheral vascular devices & accessories market size was estimated at USD 3.3 billion in 2019 and is expected to reach USD 3.4 billion in 2020.
b. The U.S. peripheral vascular devices & accessories market is expected to grow at a compound annual growth rate of 4.5% from 2020 to 2027 to reach USD 4.6 billion by 2027
b. Peripheral vascular stents dominated the U.S. peripheral vascular devices & accessories market with the highest share in 2019. This is attributable to the growing patient pool requiring immediate stent placement, technological innovations in peripheral vascular interventions, and growing government initiatives.
b. Some key players operating in the U.S. peripheral vascular devices & accessories market include Abbott Laboratories, Angioscore Inc., Edward Lifesciences Corporation, Medtronic Inc., St. Jude Medical, Teleflex Medical, Volcano Corporation, Boston Scientific Corporation, Teleflex Medical, Cook Group Inc., Cordis Corporation, Covidien, Edward Lifesciences, C.R.Bard, St. Jude Medical, Terumo Interventional Systems Inc., Bayer, Endologix, B Braun Inc., Volcano Corporation, Endologix, W.L.Gore and Associates Ltd., and Angioscore Ltd.
b. Key factors driving the U.S. peripheral vascular devices & accessories market growth include higher adoption rates of minimally invasive surgeries coupled with the presence of high patient awareness and healthcare expenditure levels.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."